In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)

Bone Marrow Transplantation

Volumn 19, Issue 4, 1997, Pages 323-329

  Dickinson, A M ^a   Reid, M M ^a   Abinun, M ^b   Peak, J ^a   Brigham, K ^a   Dunn, J ^a   Cant, A J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NONE

Author keywords

Severe combined immunodeficiency; T cell depletion

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; CELL SEPARATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; COMBINED IMMUNODEFICIENCY; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; INFANT; MALE; MONONUCLEAR CELL; PATIENT MONITORING; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

EID: 0031058173     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700669     Document Type: Article

References (21)

1. Gatti R, Meuwissen H, Allen H et al. Immunological reconstitution of sex linked lymphopenic immunological deficiency. Lancet 1968; 2: 1366-1369.
2. Reinherz EL, Geha R, Rappaport JM et al. Reconstitution after transplantation with T-lymphocyte depleted HLA-haplotype mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 1982; 79: 6047-6051.
3. Morgan G, Linch DC, Knott LT et al. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-1 monoclonal antibody and E-rosetting. Br J Haematol 1986; 62: 421-430.
4. Fischer A, Durandy A, de Villartay JP et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine. Blood 1986; 67: 444-449.
5. Fisher A, Landis P, Friedrich W et al. European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 1991; 336: 850-854.
6. Buckley RH, Schiff SE, Schiff RI et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993; 30: 92-104.
7. Vossen JM, Van Leeuwen JEM, Van Tol MJD et al. Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease. Immunodeficiency 1993; 4: 311-313.
8. Hale G, Waldmann H for CAMPATH users. CAMPATH-1 monoclonal antibodies in bone marrow transplantation. Hematotherapy 1994; 3: 15-31.
9. Gilmore M, Prentice H, Price Jones E et al. Allogenic bone marrow transplantation: the monitoring of granulocyte macrophage colonies following the collection of bone marrow mononuclear cells and after the subsequent in vitro cytolysis of OKT3 positive lymphocytes. Br J Haematol 1983; 55: 587-593.
10. Sutherland HJ, Eaves AC, Eaves CJ. Quantitative assays for human hematopoietic progenitor cells. In: Gee AP (ed). Bone Marrow Processing and Purging: A Practical Guide. CRC Press: Boca Raton, 1991, pp 155-171.
11. Sutherland RD, Keating A, Nayar R et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994; 22: 1003-1010.
12. Williamson IK, Dickinson AM, Proctor SJ. Detection of residual T-cells in T-cell depleted bone marrow: a comparison of immunofluorescence and limiting dilution culture techniques. Med Lab Sci 1989; 46: 127-134.
13. Stephan JL, Vlekova SJ, Le Deist F et al. Severe combined immunodeficiency: a retrospective single-centre study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123: 564-572.
14. Lanfranchi A, Verardi R, Neva A et al. Campath 1G for the depletion of T cells after positive selection of CD34+ cells in haploidentical BMT in primary immunodeficiencies. Bone Marrow Transplant 1996; 17 (Suppl. 1): S127.
15. Anderlini P, Korbling M, Miller P et al. Allogeneic peripheral blood progenitor cell (PBPC) transplantation: collection of filgrastim-mobilized PBPCs from normal donors weighing 40 kg or less. Bone Marrow Transplant 1996; 17 (Suppl. 1): S57.
16. Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency disease with HLA A, B, D, DR incompatible parental marrow fractionated by soy bean agglutinin and sheep red blood cells. Blood 1983; 61: 341-348.
17. Fischer A, Landais P, Friedrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European group for BMT and the European Group for Immunodeficiency. Blood 1994; 83: 1149-1154.
18. Friedrich W, Knobloch C, Greher J et al. Bone marrow transplantation in severe combined immunodeficiency: potential and current limitations. Immunodeficiency 1993; 4: 315-322.
19. Cant AJ. Severe combined immunodeficiency clinicopathological features and treatment. In: Proctor SJ (ed). Forum Trends Exp Clin Med 1995; 5: 6-19.
20. Reisner Y, Martelli F. Bone marrow transplantation across HLA barriers by increasing the numbers of transplanted cells. Immunol Today 1995; 16: 437-440.
21. Hale G. Report of CAMPATH Users Meeting. 1996, pp 1-25.